BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18345611)

  • 21. Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivatives as potent antimalarial agents.
    Pandey S; Agarwal P; Srivastava K; Rajakumar S; Puri SK; Verma P; Saxena JK; Sharma A; Lal J; Chauhan PM
    Eur J Med Chem; 2013 Aug; 66():69-81. PubMed ID: 23792317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microwave-promoted facile access to 4-aminoquinoline-phthalimides: Synthesis and anti-plasmodial evaluation.
    Rani A; Singh A; Gut J; Rosenthal PJ; Kumar V
    Eur J Med Chem; 2018 Jan; 143():150-156. PubMed ID: 29174811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimalarials with Benzothiophene Moieties as Aminoquinoline Partners.
    Konstantinović J; Videnović M; Srbljanović J; Djurković-Djaković O; Bogojević K; Sciotti R; Šolaja B
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28245583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplasmodial activities of 4-aminoquinoline-statine compounds.
    Vaiana N; Marzahn M; Parapini S; Liu P; Dell'Agli M; Pancotti A; Sangiovanni E; Basilico N; Bosisio E; Dunn BM; Taramelli D; Romeo S
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5915-8. PubMed ID: 22884991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of functionalized 3-, 5-, 6- and 8-aminoquinolines via intermediate (3-pyrrolin-1-yl)- and (2-oxopyrrolidin-1-yl)quinolines and evaluation of their antiplasmodial and antifungal activity.
    Vandekerckhove S; Van Herreweghe S; Willems J; Danneels B; Desmet T; de Kock C; Smith PJ; Chibale K; D'hooghe M
    Eur J Med Chem; 2015 Mar; 92():91-102. PubMed ID: 25544689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Aminoquinoline-chalcone/-N-acetylpyrazoline conjugates: Synthesis and antiplasmodial evaluation.
    Kumar S; Saini A; Gut J; Rosenthal PJ; Raj R; Kumar V
    Eur J Med Chem; 2017 Sep; 138():993-1001. PubMed ID: 28756265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 8-Aminoquinolines with an Aminoxyalkyl Side Chain Exert in vitro Dual-Stage Antiplasmodial Activity.
    Leven M; Held J; Duffy S; Alves Avelar LA; Meister S; Delves M; Plouffe D; Kuna K; Tschan S; Avery VM; Winzeler EA; Mordmüller B; Kurz T
    ChemMedChem; 2019 Feb; 14(4):501-511. PubMed ID: 30605243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives.
    Bhat HR; Singh UP; Thakur A; Kumar Ghosh S; Gogoi K; Prakash A; Singh RK
    Exp Parasitol; 2015 Oct; 157():59-67. PubMed ID: 26164360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimalarial activity of novel 4-aminoquinolines active against drug resistant strains.
    Kondaparla S; Soni A; Manhas A; Srivastava K; Puri SK; Katti SB
    Bioorg Chem; 2017 Feb; 70():74-85. PubMed ID: 27908538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of ring-substituted 4-aminoquinolines and evaluation of their antimalarial activities.
    Madrid PB; Sherrill J; Liou AP; Weisman JL; Derisi JL; Guy RK
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1015-8. PubMed ID: 15686903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antiplasmodial evaluation of 1H-1,2,3-triazole grafted 4-aminoquinoline-benzoxaborole hybrids and benzoxaborole analogues.
    Saini A; Kumar S; Raj R; Chowdhary S; Gendrot M; Mosnier J; Fonta I; Pradines B; Kumar V
    Bioorg Chem; 2021 Apr; 109():104733. PubMed ID: 33618251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antimalarial activity of novel side chain modified antimalarial agents derived from 4-aminoquinoline.
    Solomon VR; Haq W; Smilkstein M; Srivastava K; Rajakumar S; Puri SK; Katti SB
    Med Chem; 2008 Sep; 4(5):446-56. PubMed ID: 18782041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-Aminoquinoline-pyrimidine hybrids: synthesis, antimalarial activity, heme binding and docking studies.
    Kumar D; Khan SI; Tekwani BL; Ponnan P; Rawat DS
    Eur J Med Chem; 2015 Jan; 89():490-502. PubMed ID: 25462261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of aminoquinoline-based aminoalcohols and oxazolidinones and their antiplasmodial activity.
    Kobarfard F; Yardley V; Little S; Daryaee F; Chibale K
    Chem Biol Drug Des; 2012 Mar; 79(3):326-31. PubMed ID: 22129095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-amino-alcohol tethered 4-aminoquinoline-isatin conjugates: synthesis and antimalarial evaluation.
    Nisha ; Gut J; Rosenthal PJ; Kumar V
    Eur J Med Chem; 2014 Sep; 84():566-73. PubMed ID: 25062007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporation of a 3-(2,2,2-trifluoroethyl)-γ-hydroxy-γ-lactam motif in the side chain of 4-aminoquinolines. Syntheses and antimalarial activities.
    Cornut D; Lemoine H; Kanishchev O; Okada E; Albrieux F; Beavogui AH; Bienvenu AL; Picot S; Bouillon JP; Médebielle M
    J Med Chem; 2013 Jan; 56(1):73-83. PubMed ID: 23102258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trioxaferroquines as new hybrid antimalarial drugs.
    Bellot F; Coslédan F; Vendier L; Brocard J; Meunier B; Robert A
    J Med Chem; 2010 May; 53(10):4103-9. PubMed ID: 20443628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives.
    Chiyanzu I; Clarkson C; Smith PJ; Lehman J; Gut J; Rosenthal PJ; Chibale K
    Bioorg Med Chem; 2005 May; 13(9):3249-61. PubMed ID: 15809160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and antimalarial activities of "trioxaquines", new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline.
    Dechy-Cabaret O; Benoit-Vical F; Robert A; Meunier B
    Chembiochem; 2000 Nov; 1(4):281-3. PubMed ID: 11828420
    [No Abstract]   [Full Text] [Related]  

  • 40. Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases.
    Warhurst DC; Craig JC; Adagu IS; Guy RK; Madrid PB; Fivelman QL
    Biochem Pharmacol; 2007 Jun; 73(12):1910-26. PubMed ID: 17466277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.